A Clinical Study Comparing Standard Anastomosis Closure Technique to Standard Closure Technique Plus Sylys® Surgical Sealant

NCT ID: NCT02960139

Last Updated: 2018-06-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

61 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-04-13

Study Completion Date

2018-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The Cohera Sylys® Surgical Sealant study is a pivotal, prospective, randomized, controlled, multicenter superiority clinical study comparing standard anastomosis closure technique (Control) to standard closure technique plus Sylys® Surgical Sealant (Test) during stapled colorectal and ileorectal anastomosis procedures.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Colorectal and Ileorectal Anastomosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Test- Treatment with Sylys Surgical Sealant

Standard closure plus treatment with Sylys Surgical Sealant

Group Type EXPERIMENTAL

Test- Treatment with Sylys Surgical Sealan

Intervention Type DEVICE

Standard closure of stapled anastomosis plus treatment with Sylys Surgical Sealant

Control- Standard of Care

Control group is standard closure of anastomosis.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Test- Treatment with Sylys Surgical Sealan

Standard closure of stapled anastomosis plus treatment with Sylys Surgical Sealant

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Be at least 22 years of age
* Be scheduled for a stapled colorectal or ileorectal anastomosis procedure with or without diverting stoma
* Agree to return for all follow-up evaluations and procedures specified in the protocol
* Understand and give informed consent

Exclusion Criteria

* Albumin \< 3
* ASA ≥ 4
* Neutropenia ≤ 800
* Pregnancy
* The following conditions involving compromised immune system: AIDS (HIV positive not excluded), neutropenia
* Known blood clotting disorder requiring treatment
* Any condition known to effect wound healing, such as collagen vascular disease
* Have known or suspected allergy or sensitivity to any test materials or reagents
* Concurrent use of fibrin sealants or other anastomosis care devices
* Surgery for emergency abdominal indications
* Has undergone a colorectal anastomosis procedure in the previous two months
* Has an emergent infection related to a previous colorectal anastomosis procedure
* Is scheduled to undergo a Hartmann's procedure
* Is scheduled to undergo trans-anal endoscopic microsurgery (TEM) Is participating in another medical device trial related to colorectal anastomosis
Minimum Eligible Age

22 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cohera Medical, Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Flevoziekenhuis

Almere Stad, Flevoland, Netherlands

Site Status

Meander Medical Center

Amersfoort, , Netherlands

Site Status

OLVG

Amsterdam, , Netherlands

Site Status

AMC

Amsterdam-Zuidoost, , Netherlands

Site Status

Laurentius

Roermond, , Netherlands

Site Status

Diakonessenhuis

Utrecht, , Netherlands

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Netherlands

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PRO-106-0119

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Safe Anastomosis Feasibility Study
NCT05180565 COMPLETED NA